Skip to main content

Table 2 Perceived challenges by pharmacists during COVID-19 pandemic in wards

From: Experience and attitudes of pharmacists towards challenges and adaptive measures to new norm in ward pharmacy practice during the COVID-19 pandemic

No

Challenges

Never

n (%)

Rarely

n (%)

Occasionally

n (%)

Often

n (%)

Always

n (%)

Mean (SD)

1

Insufficient personal protective equipment (e.g.: face shield, surgical mask, N95 mask)

40 (22.9)

53 (30.3)

55 (31.4)

21 (12.0)

6 (3.4)

2.43 (1.07)

2

Shortage of staff from time to time due to quarantine

8 (4.6)

38 (21.7)

64 (36.6)

50 (28.6)

15 (8.6)

3.15 (1.01)

3

Inadequate medications for COVID-19 treatment

35 (20.0)

67 (38.3)

46 (26.3)

21 (12.0)

6 (3.4)

2.41 (1.05)

4

Frequent drug shortages for patient’s treatment

17 (9.7)

71 (40.6)

49 (28.0)

24 (13.7)

14 (8.0)

2.69 (1.08)

5

Frequent conversion of ward to manage Covid-19 patients (eg: covid ward to non-covid ward and vice versa)

19 (10.9)

28 (16.0)

62 (35.4)

52 (29.7)

14 (8.0)

3.08 (1.10)

6

Frequent changes in COVID-19 updates from the hospital management

10 (5.7)

42 (24.0)

70 (40.0)

44 (25.1)

9 (5.1)

3.00 (0.96)

7

The off-label and compassionate use of novel experimental agents

30 (17.1)

64 (36.6)

62 (35.4)

18 (10.3)

1 (0.6)

2.41 (0.91)

8

Limited internet connection to provide ward pharmacy service virtually

25 (14.3)

32 (18.3)

40 (22.9)

43 (24.6)

35 (20.0)

3.18 (1.33)

9

Difficulties in tracing patients’ own medication history within 24–48 h

10 (5.7)

39 (22.3)

72 (41.1)

37 (21.1)

17 (9.7)

3.07 (1.03)

10

Difficulties in reaching patients’ family members for medication reconciliation (family member not allowed to visit / patient is poor historian)

1 (0.6)

22 (12.6)

71 (40.6)

57 (32.6)

24 (13.7)

3.46 (0.90)

11

Family member unable to inform the patient’s medication list through phone as unsure about the name of medication

4 (2.3)

19 (10.9)

49 (28.0)

69 (39.4)

34 (19.4)

3.63 (0.99)

12

Communication barriers with patients or family members when wearing face masks and face shield

16 (9.1)

48 (27.4)

52 (29.7)

45 (25.7)

14 (8.0)

2.96 (1.11)

13

Communication barriers with patients or family members due to social distance

20 (11.4)

42 (24.0)

63 (36.0)

40 (22.9)

10 (5.7)

2.87 (1.07)

14

Delay in medication history clerking due to pending COVID-19 tests result

19 (10.9)

44 (25.1)

50 (28.6)

46 (26.3)

16 (9.1)

2.98 (1.15)

15

Difficulties to interview patient for medication history within 15 min (reduce patient contact time)

10 (5.7)

51 (29.1)

56 (32.0)

34 (19.4)

24 (13.7)

3.06 (1.13)

16

Uncertain about the accuracy and completeness of patients’ medication histories traced solely from PhIS system

5 (2.9)

29 (16.6)

61 (34.9)

58 (33.1)

22 (12.6)

3.36 (0.99)

17

Limited assessment of patients in the ward with no participation in clinical rounds with the physicians

24 (13.7)

71 (40.6)

42 (24.0)

31 (17.7)

7 (4.0)

2.58 (1.06)

18

Difficulties to discuss with prescriber for pharmacotherapy plan of patient

24 (13.7)

83 (47.4)

46 (26.3)

16 (9.1)

6 (3.4)

2.41 (0.95)

19

Patient do not own smartphone to assess virtual counselling

9 (5.1)

41 (23.4)

58 (33.1)

52 (29.7)

15 (8.6)

3.13 (1.03)

20

Patient’s digital illiteracy causing difficulties in virtual counselling

10 (5.7)

26 (14.9)

48 (27.4)

61 (34.9)

30 (17.1)

3.43 (1.11)

21

Difficulties in counselling certain medication devices (eg: difficult to assess MDI technique due to face mask wearing)

7 (4.0)

17 (9.7)

48 (27.4)

64 (36.6)

39 (22.3)

3.63 (1.06)

22

Patients had problems understanding virtual counselling videos due to language barriers

13 (7.4)

31 (17.7)

62 (35.4)

51 (29.1)

18 (10.3)

3.17 (1.07)